Delivery Order SPE2DB22D2211-SPE2DB25FRSTX
Award Date
3/6/25
Potential Completion Date
3/7/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a ceiling value of $3,534.72, is for the supply of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product. The contract is a delivery order with a firm fixed price, and has an ultimate completion date of January 23, 2025. The contract is not designated as a set-aside, indicating open...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of Quillivant XR 25 mg/5 ml suspension, a medication, and has a ceiling value of $1,577.04. The contract is a firm fixed-price Delivery Order with a completion date of January 22, 2025. The contract is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The contract is for the delivery of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles, with a ceiling value of $1,715.06 and a completion date of February 4, 2025. The contract is a delivery order under an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. This...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Quillivant XR 25 mg/5 ml suspension (180 ml). The contract has a ceiling value of $1,314.20 and a completion date of January 23, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Quillivant XR 25 mg/5 ml suspension in 180 ml bottles. The contract has a ceiling value of $4,528.40 and runs through February 10, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,184.58, is for the delivery of Quillivant XR 25 mg/5 ml suspension (120 ml), a prescription medication. The contract has an ultimate completion date of March 3, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside and was awarded through open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $5,363.07, is for the delivery of Quillivant XR, a 25 mg/5 ml suspension medication. This is a Firm Fixed Price delivery order contract with a completion date of January 8, 2025. The award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,051.36, is for the delivery of Quillivant XR 25 mg/5 ml suspension in 150 ml bottles. This is a Firm Fixed Price Delivery Order contract with a period of performance through February 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Quillivant XR 25 mg/5 ml suspension medication. The $2,102.72 firm fixed-price delivery order has a completion date of January 24, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical to supply a wide range of pharmaceutical products and medical supplies in...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Quillivant XR 25 mg/5 ml suspension in 150 ml bottles, with a ceiling value of $1,398.84 and a performance period ending on January 29, 2025. This award is not associated with a set-aside program. AmerisourceBergen also holds a...